---
title: "Psych News Alert: Risks of Adding Antipsychotics to Mood Stabilizer May Outweigh Benefits After 6 Months"
description: Following an acute manic episode, many patients with bipolar disorder are treated with a combination of a mood stabilizer and an atypical...
image: https://alert.psychnews.org/hubfs/Imported_Blog_Media/lakshmi_yatham_pp11a1_f-Jun-24-2025-07-36-16-4136-PM.png
---

 11/13/15 12:00 AM

# Risks of Adding Antipsychotics to Mood Stabilizer May Outweigh Benefits After 6 Months

![Picture of Psychiatric News Alert](https://alert.psychnews.org/hs-fs/hubfs/Psych%20News%20Email%20Banners/PN-Blue-Box_rgb.png?width=50&name=PN-Blue-Box_rgb.png) [ Psychiatric News Alert ](https://alert.psychnews.org/author/psychiatric-news-alert)

Share: [facebook-f icon ](http://www.facebook.com/share.php?u=https://alert.psychnews.org/2015/11/risks-of-adding-antipsychotics-to-mood.html) [linkedin-in icon ](http://www.linkedin.com/shareArticle?mini=true&url=https://alert.psychnews.org/2015/11/risks-of-adding-antipsychotics-to-mood.html) [Twitter icon ](https://twitter.com/intent/tweet?url=https://alert.psychnews.org/2015/11/risks-of-adding-antipsychotics-to-mood.html) [pinterest-p icon ](http://pinterest.com/pin/create/link/?url=https://alert.psychnews.org/2015/11/risks-of-adding-antipsychotics-to-mood.html) [envelope icon ](mailto:?body=https://alert.psychnews.org/2015/11/risks-of-adding-antipsychotics-to-mood.html)

| ![](https://alert.psychnews.org/hs-fs/hubfs/Imported_Blog_Media/lakshmi_yatham_pp11a1_f-4.png?width=200&height=126&name=lakshmi_yatham_pp11a1_f-4.png) |  |
| --- | --- |

Following an acute manic episode, many patients with bipolar disorder are treated with a combination of a mood stabilizer and an atypical antipsychotic to reduce the risk of a manic relapse. However, due to the side effects of antipsychotics—including weight gain and metabolic syndrome—most agree that antipsychotic therapy should be maintained only if the benefits of using the medication can be shown to outweigh the risks.

A [study](http://www.nature.com/mp/journal/vaop/ncurrent/full/mp2015158a.html) published last month in *Molecular Psychiatry* suggests six months of adjunctive antipsychotic therapy is helpful in reducing mania relapse, but beyond that there is limited benefit.

Lakshmi Yatham, M.D. (pictured above), of the Department of Psychiatry at the University of British Columbia and colleagues recruited patients with bipolar I disorder who had recently remitted from a manic episode following treatment with a mood stabilizer (lithium or valproate) and antipsychotic (risperidone or olanzapine). Patients were randomly assigned to one of three conditions: discontinuation of risperidone or olanzapine and substitution with placebo at the trial’s start (“0-week group”) or 24 weeks after entry, or continuation of the antipsychotic therapy throughout the 52-week trial.

The researchers found that patients on antipsychotics and mood stabilizers for 24 weeks following remission of their manic episode had about half the risk of relapse as patients who tapered off antipsychotics following remission (the 0-week group) and the same relapse risk as patients taking antipsychotics for the full 52 weeks. The 24-week group gained an average of 0.1 kg while the 52-week group gained an average of 3.2 kg; the 0-week group lost 0.2 kg on average.

The findings suggest that when weighing the risks and benefits of risperidone or olanzapine adjunctive therapy, 24 weeks may be the best option, Yatham told *Psychiatric News*.

For the complete report, click [here](http://psychnews.psychiatryonline.org/doi/full/10.1176/appi.pn.2015.pp11a1).

(Image: Martin Dee/UBC )

[bipolar disorder](https://alert.psychnews.org/tag/bipolar-disorder), [olanzapine](https://alert.psychnews.org/tag/olanzapine), [risperidone](https://alert.psychnews.org/tag/risperidone), [valproate](https://alert.psychnews.org/tag/valproate), [lithium](https://alert.psychnews.org/tag/lithium), [antipsychotics](https://alert.psychnews.org/tag/antipsychotics), [metabolic syndrome](https://alert.psychnews.org/tag/metabolic-syndrome), [Molecular Psychiatry](https://alert.psychnews.org/tag/molecular-psychiatry), [weight gain](https://alert.psychnews.org/tag/weight-gain), [mood stabilizers](https://alert.psychnews.org/tag/mood-stabilizers), [manic](https://alert.psychnews.org/tag/manic)

## Related posts

[![](https://alert.psychnews.org/hs-fs/hubfs/Imported_Blog_Media/iStock-629600614-Jun-24-2025-07-44-36-6059-PM.jpg?height=200&name=iStock-629600614-Jun-24-2025-07-44-36-6059-PM.jpg) ](https://alert.psychnews.org/2017/09/asenapine-more-effective-than-placebo.html)

[prevention](https://alert.psychnews.org/tag/prevention), [ajp in advance](https://alert.psychnews.org/tag/ajp-in-advance), [mood recurrence](https://alert.psychnews.org/tag/mood-recurrence), [Bipolar I](https://alert.psychnews.org/tag/bipolar-i)

## [Asenapine More Effective Than Placebo in Preventing Recurrence of Mood Episodes in Patients With Bipolar I](https://alert.psychnews.org/2017/09/asenapine-more-effective-than-placebo.html)

![Picture of Psychiatric News Alert](https://alert.psychnews.org/hs-fs/hubfs/Psych%20News%20Email%20Banners/PN-Blue-Box_rgb.png?width=50&name=PN-Blue-Box_rgb.png) [Psychiatric News Alert](https://alert.psychnews.org/author/psychiatric-news-alert) 

 9/28/17 12:00 AM

Long-term treatment with asenapine, an atypical antipsychotic approved for treatment of bipolar...

[ Read more ](https://alert.psychnews.org/2017/09/asenapine-more-effective-than-placebo.html)

[![](https://alert.psychnews.org/hs-fs/hubfs/Imported_Blog_Media/car_accident_iStock-844910252-Jun-24-2025-06-28-57-7597-PM.jpg?height=200&name=car_accident_iStock-844910252-Jun-24-2025-06-28-57-7597-PM.jpg) ](https://alert.psychnews.org/2019/09/slower-memory-development-in.html)

[development](https://alert.psychnews.org/tag/development), [JAMA Network Open](https://alert.psychnews.org/tag/jama-network-open), [adolescents](https://alert.psychnews.org/tag/adolescents), [IQ](https://alert.psychnews.org/tag/iq), [impulsivity](https://alert.psychnews.org/tag/impulsivity), [working memory](https://alert.psychnews.org/tag/working-memory), [driving](https://alert.psychnews.org/tag/driving)

## [Slower Development of Working Memory in Adolescents Associated With Motor Vehicle Crashes](https://alert.psychnews.org/2019/09/slower-memory-development-in.html)

![Picture of Psychiatric News Alert](https://alert.psychnews.org/hs-fs/hubfs/Psych%20News%20Email%20Banners/PN-Blue-Box_rgb.png?width=50&name=PN-Blue-Box_rgb.png) [Psychiatric News Alert](https://alert.psychnews.org/author/psychiatric-news-alert) 

 9/16/19 12:00 AM

A person’s working memory—which helps one manage complex tasks and maintain attention when faced...

[ Read more ](https://alert.psychnews.org/2019/09/slower-memory-development-in.html)

[![](https://alert.psychnews.org/hs-fs/hubfs/Imported_Blog_Media/IMG_2333-Jun-24-2025-07-29-03-1774-PM.jpg?height=200&name=IMG_2333-Jun-24-2025-07-29-03-1774-PM.jpg) ](https://alert.psychnews.org/2013/10/psychiatrist-patient-relationship.html)

[Institute on Psychiatric Services](https://alert.psychnews.org/tag/institute-on-psychiatric-services), [severe mental illness](https://alert.psychnews.org/tag/severe-mental-illness)

## [Psychiatrist-Patient Relationship Becomes More Meaningful When Mental Illness Persists, Author Says](https://alert.psychnews.org/2013/10/psychiatrist-patient-relationship.html)

![Picture of Psychiatric News Alert](https://alert.psychnews.org/hs-fs/hubfs/Psych%20News%20Email%20Banners/PN-Blue-Box_rgb.png?width=50&name=PN-Blue-Box_rgb.png) [Psychiatric News Alert](https://alert.psychnews.org/author/psychiatric-news-alert) 

 10/11/13 12:00 AM

For patients with severe and mental illness that has persisted over many years, a psychiatrist may...

[ Read more ](https://alert.psychnews.org/2013/10/psychiatrist-patient-relationship.html)

```json
{
  "@context" : "https://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Psychiatric News Alert",
    "url" : "https://alert.psychnews.org/author/psychiatric-news-alert"
  },
  "dateModified" : "2025-06-24T19:39:52.254Z",
  "datePublished" : "2015-11-13T05:00:00.000Z",
  "headline" : "Psych News Alert: Risks of Adding Antipsychotics to Mood Stabilizer May Outweigh Benefits After 6 Months",
  "image" : [ "https://alert.psychnews.org/hubfs/Imported_Blog_Media/lakshmi_yatham_pp11a1_f-Jun-24-2025-07-36-16-4136-PM.png" ],
  "mainEntityOfPage" : {
    "@id" : "https://alert.psychnews.org/2015/11/risks-of-adding-antipsychotics-to-mood.html",
    "@type" : "WebPage"
  },
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "url" : "https://alert.psychnews.org/hubfs/PN-Blue-Box.jpg"
    }
  }
}
```